vancomycin has been researched along with Facial Dermatoses in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonavila Juan, C; Goenaga Sánchez, MÁ; Michelena Bengoechea, A; Zubeltzu Sese, B | 1 |
| Gameiro, A; Goncalo, M; Gouveia, M; Tellechea, O | 1 |
| Cheng, LH; Kang, BH | 1 |
| Duarte Reis, M; Freitas, IP; Guerra Rodrigo, F; Sousa Coutinho, V | 1 |
2 review(s) available for vancomycin and Facial Dermatoses
| Article | Year |
|---|---|
[Recurrent endocarditis due to Brevibacterium casei: case presentation and a review of the literature].
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Brevibacterium; Ceftriaxone; Disease Susceptibility; Drug Therapy, Combination; Emergencies; Endocarditis, Bacterial; Facial Dermatoses; Gentamicins; Humans; Levofloxacin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Recurrence; Tetracycline; Vancomycin; Wound Infection | 2017 |
Vancomycin-induced linear IgA bullous dermatosis: associations.
Topics: Aged; Anti-Bacterial Agents; Facial Dermatoses; Humans; Leg Dermatoses; Linear IgA Bullous Dermatosis; Male; Middle Aged; Vancomycin | 2016 |
2 other study(ies) available for vancomycin and Facial Dermatoses
| Article | Year |
|---|---|
Nasal septal abscess and facial cellulitis caused by community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Abscess; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Drainage; Facial Dermatoses; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Nasal Septum; Radiography; Sphenoid Sinusitis; Staphylococcal Infections; Vancomycin; Young Adult | 2010 |
Facial and periorbital cellulitis with orbital involvement.
Topics: Adult; Cellulitis; Drug Therapy, Combination; Eyelid Diseases; Facial Dermatoses; Female; Follow-Up Studies; Humans; Imipenem; Infusions, Intravenous; Orbital Diseases; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2002 |